MedPath

Effective dose of phenylephrine infusion for preventing hypotension in elective caesaerean deliveries.

Phase 2
Conditions
Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
Registration Number
CTRI/2019/07/020231
Lead Sponsor
DEVDUTTA RAIGUR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

>37 weeks gestation, ASA grade 2 females posted for elective caesarean delivery.

Exclusion Criteria

1. American Society of Anaesthesiologists (ASA) grade III and IV pregnant females.

2. Unwilling patients.

3. Patients with any uncontrolled systemic disorder like diabetes, hypertension, pre-eclampsia, HELLP syndrome, hepatic or renal impairment, severe airway disorder, seizure disorder or eclampsia, any cardiac diseases.

4. Patients with known hypersensitivity or allergy to either Phenylephrine.

5. Patients with any contraindication for undergoing spinal anaesthesia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
prevention of hypotension following spinal anaesthesiaTimepoint: blood pressure & heart rate recorded before spinal anaesthesia then every one min after spinal anaesthesia until baby is delivered then every 3 mins until end of surgery
Secondary Outcome Measures
NameTimeMethod
to prevent hypoxia of babyTimepoint: APGAR score at birth then after 1 min and 5 mins and 10 mins.
© Copyright 2025. All Rights Reserved by MedPath